SynAct Pharma AB banner
S

SynAct Pharma AB
STO:SYNACT

Watchlist Manager
SynAct Pharma AB
STO:SYNACT
Watchlist
Price: 17.98 SEK 3.81% Market Closed
Market Cap: kr958.9m

Wall Street
Price Targets

SYNACT Price Targets Summary
SynAct Pharma AB

Wall Street analysts forecast SYNACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SYNACT is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.

Lowest
Price Target
30.3 SEK
69% Upside
Average
Price Target
30.6 SEK
70% Upside
Highest
Price Target
31.5 SEK
75% Upside
SynAct Pharma AB Competitors:
Price Targets
PTCT
PTC Therapeutics Inc
34% Upside
TENB
Tenable Holdings Inc
80% Upside
CDNA
CareDx Inc
53% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SYNACT's stock price target?
Price Target
30.6 SEK

According to Wall Street analysts, the average 1-year price target for SYNACT is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett